Why psychotic patients are not drug compliant?;Pourquoi les patients souffrant de troubles psychotiques ne sont-ils pas observants à leurs médicaments?

Encephale

Volumn 29, Issue 3 I, 2003, Pages 213-222

  Bordenave Gabriel, C ^a   Giraud Baro, E ^a   De Beauchamp, I ^a   Bougerol, T ^b   Calop, J ^b  

^a CHS de Saint Egreve   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antipsychotics; Drug compliance; Epidemiological survey; Psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ADDICTION; ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT COMPLIANCE; PSYCHOSIS; PUBLICATION; QUESTIONNAIRE; SOCIAL PSYCHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SOCIAL ENVIRONMENT;

EID: 0038787807     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. AMARASINGHAM LR. Social and cultural perspective on medication refusal. Am J Psychiatry 1980; 137: 340-6.
2. BECKER MH, MAIMAN LA. Sociobehavioral Determinants of Compliance with Health and Medical Care Recommandations. Med Care 1975; 13, 1: 10-24.
3. BLONDIAUX I, ALAGILE M, GINESTET D. Adhésion aux traitements biologiques en psychiatrie. In: Editions techniques, Encycl Med Chir, Psychiatrie, A50, 37. Paris 1994: 860-2.
4. BOURIN M, SLEIMAN N La non-adhésion au traitement médicamenteux. Psychol Med 1987; 19, 7: 1013-20.
5. DAIRES LM, DRUMMOND MF. Economics and schizophrenia: the real cost. Br J Psychiatry 1994; 165 (Suppl 25): 18-21.
6. DECCACHE A. Quelles pratiques et compétences en éducation du patient? Sant Homme 1999; 341: 12-4.
7. DEMYTTENAERE K. Compliance during treatment with antidepressants. J Affect Disord 1997; 43: 27-39.
8. DUCLOS K. Réflexions sur les déterminants de l'observance thérapeutique. Perspect Psy 2000; 39, 1: 52-9.
9. FRANCK AF, GUNDERSON JG. The role of the therapeutic alliance in the treatment of schizophrenia. Arch Gen Psychiatry 1990; 47: 228-36.
10. GOZLAN M. Observance thérapeutique: l'affaire de tous. Pharmaceutiques 1998; 58.
11. HOWLAND JS, BAKER MG, POE T. Does patient education cause side effects? J Farm Pract 1990; 31: 62-64.
12. KAMPMAN D, LEHTINEN K. Compliance in psychoses. Acta Psychiatr Scand 1999; 100: 167-75.
13. MORON P, SCHMITT L. Pédagogie de l'observance médicamenteuse. Psychol Med 1991; 23, 6: 682-6.
14. OLIVIER-MARTIN R. Facteurs psychologiques, observance et résistance aux traitements antidépreseurs. Encephale 1986; 12: 197-203.
15. ROSENSTOCK IM. Historical origins of the Health Belief Model. Health Educ Monogr 1974; 2: 238-335.
16. SAOUD M, DALERY J. Compliance aux neuroleptiques et effets extrapyramidaux dans la pratique psychiatrique. Inform Psychiatr 1998; 7: 704-10.
17. SCHMITT L, ESPITALIER F, PERESSON G et al. Observance médicamenteuse en psychiatrie: l'opinion du patient. Psychol Med 1990; 22 (6): 521-4.
18. SERRHEL GA, HOWE JT. Predicting medication complication in psychotic population. J Nerv Ment Dis 1993; 181: 558-60.
19. TAZAROURTE M, CATTEAU J, FALLA et al. Coût de l'inobservance aux psychotropes. Synapse 1999; 154: 27-30.
20. VAN PUTTEN T. Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry 1974; 31: 67-72.